Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Korean J Intern Med
Autores principales: Jung, Seung Min, Kwok, Seung-Ki, Ju, Ji Hyeon, Park, Yong-Beom, Park, Sung-Hwan
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/
https://ncbi.nlm.nih.gov/pubmed/29172405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares